In Phase 3 TRIUMPH-4, about 20.9% of participants at the highest dose reported dysesthesia, which means unusual skin sensitivity or tingling
(Midi does not prescribe this or other unapproved peptides.) What the science says: Ipamorelin has more clinical data than many other peptides featured in this guide, but the evidence is still lacking
Teskey G, Abraham R, Cao R, Gyurjian K, Islamoglu H, Lucero M, Martinez A, Paredes E, Salaiz O, Robinson B, Venketaraman V
It also supports better leg arterial circulation in those with compromised blood flow
Room temperature dramatically accelerates degradation
Your healthcare provider will be able to assess your skin type, evaluate your health history, and determine if glutathione injections are a suitable option for you